Concert Genetics

Genetic Testing is Key to Precision Medicine, but Rapid Market Changes Make it Extremely Complex. Today, there are over 75,000 unique genetic testing products on the market, with an average of 10 new products added each day. This growth disrupts the sequencing, results, billing, and reimbursement processes for tests.Concert Genetics (formerly NextGxDx, Inc.), founded in 2010, is a healthcare technology company dedicated to simplifying the selection, ordering, payment, and management of genetic testing for clinicians, hospitals, laboratories, and health plans.With the help of a leadership team composed of clinicians, researchers, data scientists, and software engineers, Concert Genetics launched its proprietary solution for end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to ensuring payment integrity and predicting pricing and usage trends.